Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Thoracic aortic aneurysm (TAA) is life-threatening once developing to dissection (TAAD) or rupture and currently there is no effective pharmacological treatment. The abnormal activity of inducible nitric oxide synthase (iNOS) has been related with syndromic TAA, but its potential role in non-syndromic TAA is unknown. Here we identified elevations of inducible nitric oxide synthase (iNOS) and its downstream protein kinase G1 (PRKG1) in both human non-syndromic TAA and β-aminopropionitrile (BAPN)-induced mouse model of TAA. The iNOS-specific inhibitor 1400W effectively inhibited the formation of BAPN-induced TAA and TAAD in mice, improved aortic extracellular matrix (ECM) degradation, and reduced TAAD-associated death. The protective effect of 1400W on TAA was likely achieved by decreasing mitochondrial fusion and increasing mitochondrial fission, along with reduced reactive oxygen species (ROS) production and increased NAD/NADH level, in human aortic vascular smooth muscle cells (HASMCs). In conclusion, here we confirm the protective effect of 1400W on non-syndromic TAA and suggest the value of regulating the iNOS-PRKG1-mitochondrial dynamics signaling in the treatment of non-syndromic TAA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejphar.2025.178071 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inhibition of inducible nitric oxide synthase (iNOS) alleviates thoracic aortic aneurysm by regulating mitochondrial dynamics.
Eur J Pharmacol
August 2025
Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan, China; Department of Physiology, Shanxi Medical University, Taiyuan, China. Electronic address:
Thoracic aortic aneurysm (TAA) is life-threatening once developing to dissection (TAAD) or rupture and currently there is no effective pharmacological treatment. The abnormal activity of inducible nitric oxide synthase (iNOS) has been related with syndromic TAA, but its potential role in non-syndromic TAA is unknown. Here we identified elevations of inducible nitric oxide synthase (iNOS) and its downstream protein kinase G1 (PRKG1) in both human non-syndromic TAA and β-aminopropionitrile (BAPN)-induced mouse model of TAA.
View Article and Find Full Text PDFMitochondrial Dysfunction: A New Hallmark in Hereditable Thoracic Aortic Aneurysm Development.
Cells
April 2025
Laboratory of Vascular Pathology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Thoracic aortic aneurysms (TAAs) pose a significant health burden due to their asymptomatic progression, often culminating in life-threatening aortic rupture, and due to the lack of effective pharmacological treatments. Risk factors include elevated hemodynamic stress on the ascending aorta, frequently associated with hypertension and hereditary genetic mutations. Among the hereditary causes, Marfan syndrome is the most prevalent, characterized as a connective tissue disorder driven by mutations that lead to life-threatening thoracic aortic ruptures.
View Article and Find Full Text PDFGene as a Novel Cause of Thoracic Aortic Aneurysm in Patients with Tricuspid Aortic Valve: Two Cases Reported.
Int J Mol Sci
May 2023
Molecular Diagnostics and Clinical Genetics Department (UDMGC), Hospital Universitari Son Espases, 07010 Palma de Mallorca, Spain.
Thoracic aortic aneurysms (TAA) consist of abnormal dilation or the widening of a portion of the ascending aorta, due to weakness or destructuring of the walls of the vessel and are potentially lethal. The congenital bicuspid aortic valve (BAV) is considered a risk factor for the development of TAA because asymmetric blood flow through the bicuspid aortic valve detrimentally influences the wall of the ascending aorta. mutations have been associated with non-syndromic TAAs as a consequence of BAV, but little is known regarding its haploinsufficiency and its relationship with connective tissue abnormalities.
View Article and Find Full Text PDFThe genetic basis of thoracic aortic disease: The future of aneurysm classification?
Hellenic J Cardiol
February 2023
Clinical Genetics and Genomics Laboratory, Royal Brompton Hospital, London, UK.
The expansion in the repertoire of genes linked to thoracic aortic aneurysms (TAA) has revolutionised our understanding of the disease process. The clinical benefits of such progress are numerous, particularly helping our understanding of non-syndromic hereditary causes of TAA (HTAAD) and further refinement in the subclassification of disease. Furthermore, the understanding of aortic biomechanics and mechanical homeostasis has been significantly informed by the discovery of deleterious mutations and their effect on aortic phenotype.
View Article and Find Full Text PDFLow copper levels measured in the aortic wall of New Zealand patients with non-syndromic ascending thoracic aortic aneurysm.
Interact Cardiovasc Thorac Surg
September 2022
Science and Engineering, University of Waikato, Hamilton, New Zealand.
Objectives: Studies in animals have shown causal relationships between copper (Cu) deficiency and the development of thoracic aortic aneurysms (TAAs) [1, 2]. Cu deficiency is widespread in New Zealand (NZ) soils; the high soil pH from the use of lime fertilizers reduces the bioavailability of Cu for grazing animals and growing plants; this, in turn, reduces Cu availability in the NZ human food chain. Our study is a pilot study to explore associations between Cu and TAA.
View Article and Find Full Text PDF